1. Home
  2. COFS vs RGNX Comparison

COFS vs RGNX Comparison

Compare COFS & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChoiceOne Financial Services Inc.

COFS

ChoiceOne Financial Services Inc.

HOLD

Current Price

$34.16

Market Cap

493.9M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.67

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COFS
RGNX
Founded
1898
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.9M
528.6M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
COFS
RGNX
Price
$34.16
$9.67
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$34.00
$28.75
AVG Volume (30 Days)
88.3K
2.3M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
3.86%
N/A
EPS Growth
N/A
18.08
EPS
0.91
N/A
Revenue
$227,624,000.00
$10,393,000.00
Revenue This Year
$22.13
$51.21
Revenue Next Year
$4.47
$19.08
P/E Ratio
$37.77
N/A
Revenue Growth
63.64
126.48
52 Week Low
$26.10
$5.46
52 Week High
$34.90
$16.19

Technical Indicators

Market Signals
Indicator
COFS
RGNX
Relative Strength Index (RSI) 57.54 41.15
Support Level $29.98 $9.51
Resistance Level $34.88 $10.16
Average True Range (ATR) 1.31 0.93
MACD -0.01 -0.46
Stochastic Oscillator 88.15 16.60

Price Performance

Historical Comparison
COFS
RGNX

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: